E Thehiloe ka 2009, JYMed ke mofani oa litšebeletso tse ka sehloohong tsa peptide CRDMO le moetsi oa API ea generic naheng ea China e sebetsanang le tloaelo ea ho kopanya, nts'etsopele ea ts'ebetso, phepelo ea bongaka le thekiso ea lintho tsa peptide. Khamphani e sebelisa li-FTEs tse ka bang 600+, tse nang le sehlopha sa batsamaisi ba mantlha se entsoeng ka litsebi tse nang le boiphihlelo ba lilemo tse fetang 20 tsa theknoloji ea peptide. JYMed e sebetsa setsi se le seng sa R&D le lits'ebeletso tse peli tse kholo tsa tlhahiso ea merero e mengata, tse nang le matla a tlhahiso ea lithane tse ngata tsa peptide.
Joalo ka k'hamphani e shebaneng le bareki, JYMed e fana ka sethala se felletseng sa nts'etsopele ea peptide le ts'ebetso ea indasteri e tšehelitsoeng ke lilemo tse fetang 20 tsa boiphihlelo ba R&D le lits'ebeletso tsa morao-rao. Re fana ka li-peptide tsa boleng bo holimo tse etselitsoeng litlhoko tsa moreki e mong le e mong.
JYMed e fana ka potefolio e pharaletseng ea li-API tsa peptide tse fetang 20, ho kenyelletsa Semaglutide, Tirzepatide, Liraglutide, Degarelix, le Oxytocin. Tse 'maloa tsa tsona, tse kang Semaglutide le Tirzepatide, li atlehile ho qeta ho ngolisa le ho etsa khoebo.
JYMed e fana ka sethala sa CDMO se felletseng le se sebetsang hantle, se fana ka lits'ebeletso tse felletseng bakeng sa lihlahisoa tsa peptide le analoge ea peptide. Sena se kenyelletsa lipatlisiso le tlhahiso ea li-peptide tsa kalafo, li-peptide tsa bongaka ba liphoofolo, le tse ling.
JYMed e fana ka li-peptide tsa cosmetic tsa boleng bo holimo, lisebelisoa tse tala, le liforomo tsa OEM ho tloha lipatlisisong ho isa sehlopheng sa cGMP — kaofela li tlas'a taolo e thata ea boleng. Li-peptide tsa rona tsa maiketsetso li ratoa haholo bakeng sa polokeho ea tsona, bohloeki le boiketlo ba tsona.
JYMed ke moetsi oa lipeptide o hlahlobiloeng ke FDA oa US ea sebetsanang le li-peptide tsa litlolo, li-API tsa li-peptide le li-peptide tsa tloaelo. Lihlahisoa tsa rona tse hlahang li kenyelletsa Semaglutide, Liraglutide, Tirzepatide, Oxytocin, GHK, GHK-Cu, Acetyl Hexapeptide-8, le ho feta. Ho ithuta haholoanyane, ka kopo ikopanye le rona ho:
Email: jymed@jymedtech.com

JYMed Peptide e thabetse ho u memela Pharmaconex 2025, e tla etsahala ho tloha ka Loetse 1–3, 2025, Setsing sa Lipontšo sa Machaba sa Egypt (EIEC) se Cairo. E koahela sebaka sa lipontšo sa lisekoere-mithara tse 12,000+, ketsahalo e tla amohela babali ba 350+ mme e lebelletsoe ho hohela litsebi tse fetang 8,000+ ...

JYMed Peptide e thabetse ho u memela CPhI Korea 2025, e tla etsahala ho tloha ka Phato 26–28, 2025, Setsing sa Kopano sa COEX & Exhibition se Seoul. E nka sebaka sa lisekoere-mithara tse 15,000, ketsahalo e lebelletsoe ho amohela ba bonts'ang ba fetang 450 le ho amohela baeti ba fetang 10,000 ba litsebi. Ka 2024...

Re thabetse ho ikopanya le baetapele ba indasteri ho CPHI South East Asia 2025, ho tloha ka Phupu 16 ho isa la 18 ho MITEC Kuala Lumpur. Ketsahalo ena e feta lisekoere-mithara tse 15,000 'me e tla ba le bahoeletsi ba ka bang 400. Ho lebelletsoe hore litsebi tse fetang 8,000 li tla ba teng, hammoho le liseminara le liforamu tse fetang 60+ ...